| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.53▼ | 2.52▼ | 2.52▼ | 2.53▼ | 2.34▲ |
| MA10 | 2.52▼ | 2.53▼ | 2.56▼ | 2.46▼ | 2.24▲ |
| MA20 | 2.56▼ | 2.56▼ | 2.57▼ | 2.32▲ | 2.22▲ |
| MA50 | 2.57▼ | 2.55▼ | 2.49▼ | 2.22▲ | 1.90▲ |
| MA100 | 2.56▼ | 2.41▲ | 2.32▲ | 2.23▲ | 2.21▲ |
| MA200 | 2.46▼ | 2.28▲ | 2.29▲ | 1.97▲ | 1.87▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.006▼ | -0.013▼ | -0.018▼ | 0.024▲ | 0.013▲ |
| RSI | 32.678▼ | 36.738▼ | 40.055▼ | 57.094▲ | 57.119▲ |
| STOCH | 57.532 | 24.902 | 20.971 | 69.153 | 64.222 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -45.918 | -22.061▲ |
| CCI | -243.879▼ | -186.513▼ | -205.852▼ | 48.577 | 139.478▲ |
|
Thursday, December 11, 2025 04:00 PM
Aytu BioPharma Inc. Annual cash flow by MarketWatch. View AYTU net cash flow, operating cash flow, operating expenses and cash dividends.
|
|
Tuesday, September 23, 2025 06:05 AM
Exclusive agreement in June 2025 to commercialize EXXUA™ (gepirone) extended-release tablets ("EXXUA") is expected to serve as a major growth catalyst; the Company anticipates launching EXXUA in the ...
|
|
Monday, September 22, 2025 09:32 PM
• AutoZone (NYSE:AZO) is likely to report quarterly earnings at $50.86 per share on revenue of $6.24 billion. • Micron Technology (NASDAQ:MU) is expected to report quarterly earnings at $2.79 per ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/12/25 | 2.57 | 2.57 | 2.445 | 2.445 | 37,615 |
| 23/12/25 | 2.67 | 2.67 | 2.485 | 2.54 | 127,933 |
| 22/12/25 | 2.62 | 2.66 | 2.4787 | 2.65 | 122,179 |
| 19/12/25 | 2.49 | 2.60 | 2.44 | 2.55 | 134,460 |
| 18/12/25 | 2.60 | 2.6376 | 2.44 | 2.47 | 102,618 |
| 17/12/25 | 2.43 | 2.67 | 2.35 | 2.57 | 469,158 |
| 16/12/25 | 2.36 | 2.4734 | 2.32 | 2.42 | 152,829 |
| 15/12/25 | 2.39 | 2.41 | 2.32 | 2.33 | 188,973 |
| 12/12/25 | 2.30 | 2.355 | 2.28 | 2.30 | 48,276 |
| 11/12/25 | 2.32 | 2.38 | 2.27 | 2.28 | 82,772 |
|
|
||||
|
|
||||
|
|